Liminatus Pharma PE Ratio 1971-1970 | LIMN
Current and historical p/e ratio for Liminatus Pharma (LIMN) from 1971 to 1970. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Liminatus Pharma PE ratio as of May 09, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Liminatus Pharma PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-09 | 7.45 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED-DRUGS | $0.000B | $0.000B |
| Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Flowco Holdings (FLOC) | United States | $2.052B | 0.00 |
| Oaktree Acquisition III Life Sciences (OACC) | United States | $0.233B | 0.00 |
| Aduro Clean Technologies (ADUR) | Canada | $0.178B | 0.00 |
| Range Capital Acquisition (RANG) | United States | $0.142B | 0.00 |
| Tavia Acquisition (TAVI) | $0.141B | 0.00 | |
| YSX Tech (YSXT) | China | $0.102B | 0.00 |
| CO2 Energy Transition (NOEM) | United States | $0.096B | 0.00 |
| Leishen Energy Holding (LSE) | China | $0.090B | 0.00 |
| YHN Acquisition I (YHNA) | $0.082B | 0.00 | |
| Youxin Technology (YAAS) | China | $0.042B | 0.00 |
| New Century Logistics (BVI) (NCEW) | Hong Kong, SAR China | $0.028B | 0.00 |
| Sky Quarry (SKYQ) | United States | $0.015B | 0.00 |
| PicoCELA (PCLA) | Japan | $0.011B | 0.00 |
| Hong Kong Pharma Digital Technology Holdings (HKPD) | $0.010B | 0.00 | |
| Smart Digital Group (SDM) | $0.000B | 0.00 | |
| Winchester Bancorp (WSBK) | $0.000B | 0.00 | |
| Yuanbao - (YB) | China | $0.000B | 0.00 |
| Cantor Equity Partners II (CEPT) | $0.000B | 0.00 |